Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09NBP
|
||||
| Former ID |
DNC011263
|
||||
| Drug Name |
(3-Bromobenzoylpyridine)thiosemicarbazone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531200] | ||
| Formula |
C13H11BrN4S
|
||||
| Canonical SMILES |
C1=CC(=CC(=C1)Br)C(=NNC(=S)N)C2=CN=CC=C2
|
||||
| InChI |
1S/C13H11BrN4S/c14-11-5-1-3-9(7-11)12(17-18-13(15)19)10-4-2-6-16-8-10/h1-8H,(H3,15,18,19)/b17-12-
|
||||
| InChIKey |
DPTPEKAUCAAQNG-ATVHPVEESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [531200] | |
| NetPath Pathway | IL4 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.